Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

EMA validates MAA for Xyndari for sickle cell disease

March 13, 2018

Sigilon Therapeutics' SIG-003 awarded EMA ATMP designation

March 12, 2018

FDA grants orphan drug designation to PTG-300 for beta-thalassemia

March 7, 2018

IRP1 targeting ameliorates Chuvash polycythemia in mice

March 2, 2018

European Commission approves Hemlibra

Feb. 28, 2018

Novo Nordisk submits regulatory applications for N8-GP in U.S. and E.U.

Feb. 28, 2018

FDA grants priority review to lusutrombopag NDA

Feb. 27, 2018

EMA committee recommends change to marketing authorization terms for Feraccru

Feb. 26, 2018

Overall survival improved with OMS-721 in thrombotic microangiopathy trial

Feb. 16, 2018

Oxford BioMedica enters collaboration and license agreement with Bioverativ in hemophilia

Feb. 15, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...